
Jiazhong Zhang
VP, Chemistry
United States
San Mateo
Biotechnology
Drug Design, Medicinal Chemistry, Organic Synthesis, Drug Discovery, Synthetic Organic Chemistry
Experience

VP, Chemistry
A stealth biotech startup
Hayward, California, United States

Senior Director, Medicinal Chemistry
Plexxikon Inc.
Lead inventor of 2 first-in-class FDA-approved drugs and 6 clinical candidates: 1) Turalio® (Pexidartinib, PLX3397, CSF1R/Kit inhibitor) - FDA approved August 2, 2019; ASCO 2019 Advance of the Year 2) Zelboraf® (Vemurafenib, PLX4032; BRAF V600E mutant selective inhibitor) - FDA approved August 17, 2011; first approved drug from scaffold/fragment-based drug discovery; Prix Galien USA Award 2012 3) Clinical candidates: Plixorafenib (PLX8394, BRAF paradox breaker, Phase II), PLX5568 (CRAF), PLX5622 (brain-penetrant CSF1R selective inhibitor), PLX7486 (CSF1R/TRK dual inhibitor, Phase II); PLX51107 (BRD4), and Zavabresib (PLX2853, BRD4, Phase II).

Director, Medicinal Chemistry
Plexxikon Inc.

Principal Scientist
Plexxikon Inc.

Senior Scientist II
Plexxikon Inc.

Senior Scientist I
Plexxikon Inc.

Scientist II
Plexxikon Inc.

Scientist I
Plexxikon Inc.
Jiazhong Zhang's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.




